Literature DB >> 18179383

Role played by Toll-like receptors 2 and 4 in lipoteichoic acid-induced lung inflammation and coagulation.

Mark C Dessing1, Marcel Schouten, Christian Draing, Marcel Levi, Sonja von Aulock, Tom van der Poll.   

Abstract

BACKGROUND: The cell wall of Streptococcus pneumoniae consists of lipoteichoic acid (LTA), which is released when pneumococci are killed by either the host immune system or antibiotic treatment. Release of excessive amounts of LTA has been implicated in the toxic sequelae of severe gram-positive infection by virtue of its proinflammatory properties. Several in vitro studies have shown that LTA is recognized by Toll-like receptor (TLR) 2 and CD14. Our objective here was to investigate the inflammatory properties of S. pneumoniae LTA in vivo and the role played by TLR2, TLR4, and CD14 therein.
METHODS: Wild-type (WT), TLR2 knockout (KO), TLR4 KO, TLR2x4 double-KO, and CD14 KO mice were intranasally inoculated with highly purified pneumococcal LTA.
RESULTS: LTA induced a dose-dependent inflammatory response and activation of the coagulation and fibrinolytic pathways in a TLR2-dependent fashion. Surprisingly, TLR4 KO mice also displayed a somewhat diminished pulmonary inflammatory and coagulant response compared with WT mice, possibly as a result of absent TLR4 signaling through LTA-induced release of endogenous mediators.
CONCLUSION: Pneumococcal LTA induces a profound inflammatory response and activation of the coagulation pathway in the lungs in vivo through a TLR2-dependent route, which likely is amplified by endogenous TLR4 ligands.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18179383     DOI: 10.1086/524873

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  35 in total

1.  Bacterial lipoprotein TLR2 agonists broadly modulate endothelial function and coagulation pathways in vitro and in vivo.

Authors:  Hae-Sook Shin; Fengyun Xu; Aranya Bagchi; Elizabeth Herrup; Arun Prakash; Catherine Valentine; Hrishikesh Kulkarni; Kevin Wilhelmsen; Shaw Warren; Judith Hellman
Journal:  J Immunol       Date:  2010-12-17       Impact factor: 5.422

2.  Dysregulated inflammation as a risk factor for pneumonia in the elderly.

Authors:  Angela R Boyd; Carlos J Orihuela
Journal:  Aging Dis       Date:  2011-12       Impact factor: 6.745

Review 3.  Neutrophil recruitment to the lungs during bacterial pneumonia.

Authors:  Ann Craig; John Mai; Shanshan Cai; Samithamby Jeyaseelan
Journal:  Infect Immun       Date:  2008-11-17       Impact factor: 3.441

4.  T(H)17-Mediated Protection against Pneumococcal Carriage by a Whole-Cell Vaccine Is Dependent on Toll-Like Receptor 2 and Surface Lipoproteins.

Authors:  K Moffitt; A Howard; S Martin; E Cheung; M Herd; A Basset; R Malley
Journal:  Clin Vaccine Immunol       Date:  2015-06-03

Review 5.  Genome Editing of Food-Grade Lactobacilli To Develop Therapeutic Probiotics.

Authors:  Jan-Peter van Pijkeren; Rodolphe Barrangou
Journal:  Microbiol Spectr       Date:  2017-09

Review 6.  Humoral immune responses to Streptococcus pneumoniae in the setting of HIV-1 infection.

Authors:  Lumin Zhang; Zihai Li; Zhuang Wan; Andrew Kilby; J Michael Kilby; Wei Jiang
Journal:  Vaccine       Date:  2015-06-30       Impact factor: 3.641

Review 7.  The sweet tooth of bacteria: common themes in bacterial glycoconjugates.

Authors:  Hanne L P Tytgat; Sarah Lebeer
Journal:  Microbiol Mol Biol Rev       Date:  2014-09       Impact factor: 11.056

8.  Respiratory epithelial cells convert inactive vitamin D to its active form: potential effects on host defense.

Authors:  Sif Hansdottir; Martha M Monick; Sara L Hinde; Nina Lovan; Dwight C Look; Gary W Hunninghake
Journal:  J Immunol       Date:  2008-11-15       Impact factor: 5.422

Review 9.  Role of CD14 in lung inflammation and infection.

Authors:  Adam Anas; Tom van der Poll; Alex F de Vos
Journal:  Crit Care       Date:  2010-03-09       Impact factor: 9.097

10.  Role of Toll-like receptors 2 and 4 in pulmonary inflammation and injury induced by pneumolysin in mice.

Authors:  Mark C Dessing; Robert A Hirst; Alex F de Vos; Tom van der Poll
Journal:  PLoS One       Date:  2009-11-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.